» Articles » PMID: 33730592

SGK1 Signaling Promotes Glucose Metabolism and Survival in Extracellular Matrix Detached Cells

Abstract

Loss of integrin-mediated attachment to extracellular matrix (ECM) proteins can trigger a variety of cellular changes that affect cell viability. Foremost among these is the activation of anoikis, caspase-mediated cell death induced by ECM detachment. In addition, loss of ECM attachment causes profound alterations in cellular metabolism, which can lead to anoikis-independent cell death. Here, we describe a surprising role for serum and glucocorticoid kinase-1 (SGK1) in the promotion of energy production when cells are detached. Our data demonstrate that SGK1 activation is necessary and sufficient for ATP generation during ECM detachment and anchorage-independent growth. More specifically, SGK1 promotes a substantial elevation in glucose uptake because of elevated GLUT1 transcription. In addition, carbon flux into the pentose phosphate pathway (PPP) is necessary to accommodate elevated glucose uptake and PPP-mediated glyceraldehyde-3-phosphate (G3P) is necessary for ATP production. Thus, our data show SGK1 as master regulator of glucose metabolism and cell survival during ECM-detached conditions.

Citing Articles

The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers.

Qiao J, Yu Z, Zhou H, Wang W, Wu H, Ye J Int J Mol Sci. 2025; 26(2).

PMID: 39859324 PMC: 11765532. DOI: 10.3390/ijms26020610.


Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain.

Howard P, Zou P, Zhang Y, Huang F, Tesic V, Wu C Exp Neurol. 2024; 382:114973.

PMID: 39326820 PMC: 11536509. DOI: 10.1016/j.expneurol.2024.114973.


SGK1 suppresses ferroptosis in ovarian cancer via NRF2-dependent and -independent pathways.

Sang X, Han J, Wang Z, Cai W, Liao X, Kong Z Oncogene. 2024; 43(45):3335-3347.

PMID: 39306614 DOI: 10.1038/s41388-024-03173-3.


Anoikis in cell fate, physiopathology, and therapeutic interventions.

Mei J, Jiang X, Tian H, Rong D, Song J, Wang L MedComm (2020). 2024; 5(10):e718.

PMID: 39286778 PMC: 11401975. DOI: 10.1002/mco2.718.


EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis.

Glotzbach A, Rohlf K, Gonscharow A, Luke S, Demirci O, Begher-Tibbe B Breast Cancer Res. 2024; 26(1):87.

PMID: 38816770 PMC: 11138102. DOI: 10.1186/s13058-024-01849-y.